WO2007068841A3 - Utilisation d'une composition à base de trétinoine, d'hydroquinone et d'acétonide de fluocinolone, en accompagnement d'un peeling chimique - Google Patents
Utilisation d'une composition à base de trétinoine, d'hydroquinone et d'acétonide de fluocinolone, en accompagnement d'un peeling chimique Download PDFInfo
- Publication number
- WO2007068841A3 WO2007068841A3 PCT/FR2006/051290 FR2006051290W WO2007068841A3 WO 2007068841 A3 WO2007068841 A3 WO 2007068841A3 FR 2006051290 W FR2006051290 W FR 2006051290W WO 2007068841 A3 WO2007068841 A3 WO 2007068841A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tretinoin
- hydroquinone
- accompanied
- fluocinolone acetonide
- composition based
- Prior art date
Links
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 title abstract 4
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 title abstract 2
- FEBLZLNTKCEFIT-VSXGLTOVSA-N fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 title abstract 2
- 229960001347 fluocinolone acetonide Drugs 0.000 title abstract 2
- 229960004337 hydroquinone Drugs 0.000 title abstract 2
- 229960001727 tretinoin Drugs 0.000 title abstract 2
- 206010040844 Skin exfoliation Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Abstract
La présente invention se rapporte à l'utilisation d'une association d'hydroquinone, de trétinoïne et d'acétonide de fluocinolone pour préparer une composition destinée à prévenir et/ou diminuer les désordres hyperpigmentaires associés à l'application d'un peeling chimique de la peau.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0512677A FR2894479A1 (fr) | 2005-12-14 | 2005-12-14 | Utilisation d'une composition a base de tretinoine, d'hydroquinone et d'acetonide de fluocinolone, en accompagnement d'un peeling chimique |
FR0512677 | 2005-12-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007068841A2 WO2007068841A2 (fr) | 2007-06-21 |
WO2007068841A3 true WO2007068841A3 (fr) | 2007-08-02 |
Family
ID=36481466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2006/051290 WO2007068841A2 (fr) | 2005-12-14 | 2006-12-06 | Utilisation d'une composition à base de trétinoine, d'hydroquinone et d'acétonide de fluocinolone, en accompagnement d'un peeling chimique |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR2894479A1 (fr) |
WO (1) | WO2007068841A2 (fr) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004037201A2 (fr) * | 2002-10-25 | 2004-05-06 | Hill Dermaceuticals, Inc. | Composition de soin pour la peau a application topique |
-
2005
- 2005-12-14 FR FR0512677A patent/FR2894479A1/fr not_active Withdrawn
-
2006
- 2006-12-06 WO PCT/FR2006/051290 patent/WO2007068841A2/fr active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004037201A2 (fr) * | 2002-10-25 | 2004-05-06 | Hill Dermaceuticals, Inc. | Composition de soin pour la peau a application topique |
Non-Patent Citations (9)
Title |
---|
"Dermatology discussions - Interview with Dr Sungbin Im", PIGMENT MATTERS - AUTUMN 2005 / PUBLISHED BY MEDSENSE LTD, ON BEHALF OF GALDERMA INTERNATIONAL., no. 6, 4 January 2006 (2006-01-04), pages 11 - 12, XP002432728, Retrieved from the Internet <URL:HTTP://WWW.PIGMENTARYDISORDERSACADEMY.ORG/PIGMATTERS_Autumn_2005.PDF> * |
"Tri-LumaTM cream (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%)", PRESCRIBING INFORMATIONS, 6 April 2004 (2004-04-06), Galderma Laboratoires, L.P., Fort Worth, TX 76177, USA, XP002403787, Retrieved from the Internet <URL:http://web.archive.org/web/20040406072345/triluma.com/prescribing_info.pdf> [retrieved on 20061017] * |
BAUMANN L: "Efficacy and safety of triple-combination cream versus vehicle cream in the treatment of patients with postinflammatory hyperpigmentation", JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, C.V. MOSBY, ST. LOUIS, MO, US, P2606, vol. 52, no. 3, March 2005 (2005-03-01), pages P168, XP004788713, ISSN: 0190-9622 * |
BETH GILBERT: "TriLuma combination effective for PIH", DERMATOLOGY TIMES, ADVANSTAR COMMUNICATIONS, 1 September 2005 (2005-09-01), CLEVELAND, OH, US, XP002403792, ISSN: 0196-6197, Retrieved from the Internet <URL:http://www.dermatologytimes.com/dermatologytimes/article/articleDetail.jsp?id=178457> [retrieved on 20061017] * |
COOK-BOLDEN F ET AL: "THE USE OF A TRIPLE-DRUG COMBINATION PRODUCT AND PROCEDURES FOR THE TREATMENT OF HYPERPIGMENTARY DISORDERS", COSMETIC DERMATOLOGY, KNOLLS PUB. GROUP, CEDAR KNOLLS, NJ, US, vol. 18, no. 8, August 2005 (2005-08-01), pages 589 - 594, XP009066078, ISSN: 1041-3766 * |
GOODHEART H P: "Hyperpigmentation disorders . MELASMA, POSTINFLAMMATORY HYPERPIGMENTATION, ACANTHOSIS NIGRICANS", PRIMARY CARE, SAUNDERS, LONDON, GB, vol. 2, no. 12, December 1999 (1999-12-01), pages 923 - 924,929, XP002251799, ISSN: 0095-4543 * |
GRIMES P E: "Agents for ethnic skin peeling", DERMATOLOGIC THERAPY 2000 DENMARK, vol. 13, no. 2, 2000, pages 159 - 164, XP002403786, ISSN: 1396-0296 * |
GRIMES P,: "Treatment of pigmentary disorders in racial ethnic groups: Choosing your weapon", PIGMENT MATTERS - SUMMER 2004 / PUBLISHED BY MEDSENSE LTD, ON BEHALF OF GALDERMA INTERNATIONAL., no. 2, 6 July 2004 (2004-07-06), pages 1 - 3, XP002432653, Retrieved from the Internet <URL:HTTP://WWW.PIGMENTARYDISORDERSACADEMY.ORG/PIGMATTERS_SUMMER.PDF> * |
H. M. TOROK: "The resurgence of chemical peels", US DERMATOLOGY REVIEW 2006, TOUCH BRIEFINGS, vol. 1, December 2005 (2005-12-01), pages 88 - 91, XP001247928 * |
Also Published As
Publication number | Publication date |
---|---|
WO2007068841A2 (fr) | 2007-06-21 |
FR2894479A1 (fr) | 2007-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007014278A3 (fr) | Reduction de lymphocytes b au moyen de molecules de liaison specifique de cd37 et specifique de cd20 | |
WO2006083936A3 (fr) | Anticorps anti-ephb2 et methodes d'utilisation associees | |
WO2008100805A3 (fr) | Anticorps anti-robo4 et utilisations de ceux-ci | |
WO2007044026A3 (fr) | Compositions comportant du collagène modifié et leurs utilisations | |
WO2008054676A3 (fr) | Dispositifs médicaux et méthodes d'utilisation correspondantes | |
WO2007073484A3 (fr) | Procedes et systemes de conduite d’operations de recherche | |
WO2007092850A3 (fr) | Pulvérisateur puissant | |
WO2006099232A3 (fr) | Lingette antimicrobienne pour animaux domestiques et procedes associes | |
AU2006266167A8 (en) | Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation | |
EP1759343A4 (fr) | Procede facilitant la distribution de publicites presentant differents traitements et/ou differentes caracteristiques, telles que les publicites textuelles et les publicites en images | |
WO2008042216A3 (fr) | PROCÉDÉS, matÉriel et compositions pour gÉNÉrer de nouveaux follicules pileux et faire pousser les cheveux | |
WO2007061939A3 (fr) | Dérivés de métabolites de l'inhibiteur de hdac fk228 | |
GEP20115245B (en) | Solid preparation | |
WO2009042114A3 (fr) | Dérivés de phénazine et leurs utilisations | |
WO2007084857A3 (fr) | Procédés et compositions de traitement de troubles prolifératifs cellulaires | |
WO2009029883A3 (fr) | Procédés et compositions permettant de moduler les lymphocytes t | |
WO2007050348A3 (fr) | Inhibiteurs du canal potassique | |
WO2007095258A3 (fr) | compositions comprenant un rhamnolipide et leurs procedes d'utilisation | |
WO2007013901A3 (fr) | Stabilisation de couleur de composants chimiques aromatiques | |
WO2009013133A3 (fr) | Profilé présentant au moins une section à profil creux | |
WO2006071451A3 (fr) | Composes destines a la prevention de l'apoptose de macrophages et procedes de leur utilisation | |
WO2006098998A3 (fr) | Procedes et compositions de modulation de l'integrite vasculaire | |
WO2006105502A3 (fr) | Catheter | |
WO2008006883A3 (fr) | Benzopyranopyrazoles | |
WO2009017719A8 (fr) | Modulateurs du récepteur ccr9 et leurs procédés d'utilisation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06842101 Country of ref document: EP Kind code of ref document: A2 |